High prevalence of laminopathies among patients with metabolic syndrome
about
Human ZMPSTE24 disease mutations: residual proteolytic activity correlates with disease severityGenetics of Insulin Resistance and the Metabolic SyndromeOverlapping syndromes in laminopathies: a meta-analysis of the reported literatureThe structural basis of ZMPSTE24-dependent laminopathiesLMNA Sequences of 60,706 Unrelated Individuals Reveal 132 Novel Missense Variants in A-Type Lamins and Suggest a Link between Variant p.G602S and Type 2 DiabetesRequirements for efficient proteolytic cleavage of prelamin A by ZMPSTE24.Inner nuclear membrane proteins: impact on human disease.Lamin A/C mutants disturb sumo1 localization and sumoylation in vitro and in vivo.HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 "aging" studyMutations in LMNA modulate the lamin A--Nesprin-2 interaction and cause LINC complex alterationsNew ZMPSTE24 (FACE1) mutations in patients affected with restrictive dermopathy or related progeroid syndromes and mutation update.Lamin A tail modification by SUMO1 is disrupted by familial partial lipodystrophy-causing mutationsNovel forms of lipodystrophy: why should we care?A Heterozygous ZMPSTE24 Mutation Associated with Severe Metabolic Syndrome, Ectopic Fat Accumulation, and Dilated CardiomyopathyLipodystrophies: adipose tissue disorders with severe metabolic implications.Proteome-wide Structural Analysis of PTM Hotspots Reveals Regulatory Elements Predicted to Impact Biological Function and DiseaseNuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease.Lamin Deficiency in the Liver Sets the Stage for Nonalcoholic Steatohepatitis Development in Males.Macrophage Lamin A/C Regulates Inflammation and the Development of Obesity-Induced Insulin Resistance.OGT (O-GlcNAc Transferase) Selectively Modifies Multiple Residues Unique to Lamin A.
P2860
Q24611268-05123011-8070-413A-BE2A-58B8C8D93449Q26745624-BEF29D35-0114-46A8-B2A8-B2AE5E3B95C7Q26851708-37D61B77-EE12-40B0-9F15-DE936D8BF5D9Q27684303-8931E25C-E415-4F1B-90C4-34EE22E624E6Q33799816-F2C65E61-4977-4F2E-8798-052D5CA16431Q34166555-8F952E15-E254-4C7D-BEB8-CDC23B3D62F8Q34252203-BF9FEFA9-5E9F-4FAB-83E8-8745B3F22875Q34430381-D830C109-A184-40A8-BF28-7F0D6D016EEBQ34534986-F4C8370D-27E0-478C-BE15-D62A55D66640Q34972521-FBFD2FD1-EB22-477B-9BC6-AD60E201D518Q35150458-264357ED-F65D-44C6-A11A-BD8873B24AC8Q36587972-D2503956-39F7-4F32-B884-E8AA4846D237Q37022579-78A1A681-CC1C-4953-9B79-B5CCA965E929Q37062020-845D80B4-5688-40A9-A885-49540A89CAD5Q38400624-DCE017BE-8EA8-41D7-9EEF-59952C95D1D3Q39327102-4585E4C3-F9EC-454A-B3EB-E3C77A386E49Q45988395-162B4571-DF32-46E6-8BD9-D081E658F103Q46539120-629EB9D5-AA60-46E1-97A3-9E2C3EE5F0D1Q53687211-C2EBE993-E834-4091-A395-ECBF3B88B188Q55364768-55A7A0E8-4215-449B-A9DB-416523E367F7
P2860
High prevalence of laminopathies among patients with metabolic syndrome
description
im Juni 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 30 June 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2011
@uk
name
High prevalence of laminopathies among patients with metabolic syndrome
@en
High prevalence of laminopathies among patients with metabolic syndrome
@nl
type
label
High prevalence of laminopathies among patients with metabolic syndrome
@en
High prevalence of laminopathies among patients with metabolic syndrome
@nl
prefLabel
High prevalence of laminopathies among patients with metabolic syndrome
@en
High prevalence of laminopathies among patients with metabolic syndrome
@nl
P2093
P50
P356
P1476
High prevalence of laminopathies among patients with metabolic syndrome
@en
P2093
Andrée Robaglia-Schlupp
Anne Dutour
Bénédicte Gaborit
Catherine Badens
Fabien Angelis
Marie-Christine Alessi
Nathalie Lesavre
Pierre Cau
Pierre-Emmanuel Morange
Sébastien Courrier
P304
P356
10.1093/HMG/DDR294
P577
2011-06-30T00:00:00Z